Filing Details

Accession Number:
0001171843-17-001108
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-24 16:05:19
Reporting Period:
2017-02-22
Filing Date:
2017-02-24
Accepted Time:
2017-02-24 16:05:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
898437 Anika Therapeutics Inc. ANIK Surgical & Medical Instruments & Apparatus (3841) 043145961
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1572857 Sylvia Cheung 32 Wiggins Avenue
Bedford MA 01730
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-22 5,000 $10.99 37,725 No 4 M Direct
Common Stock Disposition 2017-02-22 1,117 $49.20 36,608 No 4 F Direct
Common Stock Disposition 2017-02-22 2,000 $49.01 34,608 No 4 S Direct
Common Stock Acquisiton 2017-02-22 5,000 $6.99 39,608 No 4 M Direct
Common Stock Disposition 2017-02-22 1,193 $49.05 38,415 No 4 S Direct
Common Stock Disposition 2017-02-22 807 $49.02 37,608 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2017-02-22 5,000 $0.00 5,000 $10.99
Common Stock Stock Option (Right to buy) Disposition 2017-02-22 4,193 $0.00 4,193 $6.99
Common Stock Stock Option (Right to buy) Disposition 2017-02-22 807 $0.00 807 $6.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
20,000 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. Exercise of stock appreciation rights ("SARS") granted on January 31, 2008, which vested in full on such date, and expiring on January 31, 2018.
  2. Reflects 1,117 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on February 22, 2017.
  3. Exercise of 4,193 stock options granted on June 7, 2011 that are fully vested.
  4. Exercise of 807 stock options granted on June 7, 2011 that were fully vested.